Hepatitis C New Zealand

July 23, 2010

100% Pure New Zealand Hepatitis C

100% Pure New Zealand Hepatitis C

Who do I have to tell if I have Hepatitis C In New Zealand?

Hepatitis C and Disclosure

Someone asked about Hepatitis C and disclosure

With some help from the Hepatitis C resources Centre Dunedin and the New Zealand

Ministry of Health the definitive reply seems to be.

DISCLOSURE
A person with hepatitis C is not legally required to disclose his/her positive

status unless he/she is,
*A member of, or applying to join, the New Zealand defense force.
*A healthcare worker undertaking exposure-prone procedures.
*Donating blood.

Page 19 of the little yellow book of Hep C Facts,:

If you would like a copy of   the little yellow book of Hep C Facts ring

Hepatitis C Helpline New Zealand 0800 224372 (0800 22 HEPC) or email  the Otago

Hepatitis C Resource Centre hepcotago @xtra.co.nz

Hep C Concert Christchurch

Thank you to Roger Grauwmeijer Rokpx.com Roger@RokPx.com for the images from the day May 22 concert in thepark

chch11

chch82

Dunedin opened it’s new Hepatitis C resource centre

photos were taken speeches were made.

hepcopen2

An article about the opening and the centre’s worker Heath Te Au appeared in the

Otago Daily Times,

” Fresh chance inspires hepatitis C educator

Having a ruptured appendix in the 1990s may have helped save Heath Te Au’s life.

Blood tests taken at the time of this medical emergency showed that he had hepatitis C, most likely the result of sharing needles and drug equipment during a time when he was an intravenous drug user.

After his appendix removal a doctor asked him to think about what he was doing to himself.

Mr Te Au (40) said it was a wake-up call, something which led him to change his life.

He underwent treatment in 1999 and 2000 and is now clear of the blood-borne virus which had been caught early enough not to cause major liver damage.

Now, he uses his experience to help educate others in his role as manager and one of two educators at Otago’s Hepatitis C Resource Centre. ”

Where are the Hepatitis C Resources for Wellington ?

A very large proportion of the population have no access to hepatitis C resources

its’ dysfunctional and emphasis the New Zealand’s Ministry of Health’s complete

failure to address the needs of those affected and infected by the Hepatitis C

epidemic.

The New Zealand Ministry of health attempts to contact the victims of Croydon Day Clinic

Hep C tracking hampered by privacy issues

Health authorities have tested more than half the women in New Zealand potentially exposed to the hepatitis C virus in a Melbourne abortion clinic, but are being hampered by confidentiality rules which mean they cannot leave phone messages.

Fifty-six New Zealand women have called the Ministry of Health’s Healthline, concerned they had contracted the virus after James Latham Paters, an anaesthetist at Melbourne’s Croydon Day Surgery Clinic was now being investigated by police and medical authorities. More than 20 of his patients tested positive to a strain of hepatitis C identical to his own.

“The Australian Victorian health authorities have contacted 33 New Zealanders and the bulk of those have been tested,” said the ministry’s director of public health, Fran McGrath.

The New Zealand test result figures would be released as part of the Australian report once the contacting and testing process was completed. The ministry expected to have a further update in September.

Dr McGrath said contacting the women was a slow process because confidentiality requirements meant callers could not leave messages and had to repeatedly ring back.

“Even contacting one individual can take several calls followed by a registered letter, all of which can take a considerable period of time.”

http://www.stuff.co.nz/national/health/3918567/Hep-C-tracking-hampered-by-privacy-issues

Hepatitis C Resource Centre Otago Stakeholders Meeting June 16

Hep C Seminar Dunedin

Insights offered on hepatitis C, services

“Recent concern about the risk of hepatitis C to women who may have been treated at a private medical clinic in Melbourne highlights the need for increased awareness about the illness, clinical nurse specialist Margaret Fraser says.

Ms Fraser, who is the chairwoman of the reference group for Otago’s Hepatitis C Resource Centre, said there was still widespread ignorance about the condition.

http://www.odt.co.nz/news/dunedin/110725/insights-offered-hepatitis-c-services

After sorting out my family commitments I arrived late at 9.20 so missed the

Opening / powhiri ,  Heath Te Au , Hepatitis C Resource Centre Otago who works as

a phlebotomist and the needle exchange and Margaret Fraser the hepatitis c nurse

from Dunedin Hospital speaking about  Epidemiology and treatment of Hepatitis C

apologies that I missed them speaking.

Dr Janet Downs from the free doctor’s clinic at DIVO the Dunedin needle exchange

talked about  Hepatitis C in the community. She spoke eloquently about her work

at the needle exchange, if you live in Dunedin / Otago and want to see her at the

needle exchange free clinic for IDU Intravenous Drug Users ring the needle

exchange and make an appointment

Dr Michael Schultz, Hepatitis C and what happens if you decide against treatment

was the next speaker.

Key points  “everybody should be treated the earlier the better”

The younger you are when you begin treatment the better chance of a successful

outcome

There were some unique and disturbing aspects to the policy ?  of the Southern

District Heath Board

1, people are not able to get a second course of treatment if the first course

fails to successfully clear the hepatitis c virus.   One strike and you’re out

this just seems to be harsh when retreatment is an option in other DHB’s.

2, You have to have a biopsy in the Southern region ( Dr Schultz couldn’t

understand why anyone would complain about a biopsy as they obviously didn’t have

a problem with needles?)

A professional contact sent us this, “I contacted leading  NZ specialist expert

to clarify who needs a biopsy and who doesn’t.   Here is the response: “We have

never needed a biopsy for Gt 1 or HIV infected or haemophilia.  Only change is

for Gt 2 and 3 where now Peg/RBV is available to all rather than just those with

severe fibrosis.”
In the past only G2/G3 who has severe fibrosis could access funding, therefore

for this to be determined, a liver biopsy was needed.  The new funding for

treatment now includes all G2/G3 hep C patients; hence a liver biopsy may not be

necessary.
Interesting sounds like you may not have to have a biopsy in other DHB’s.

If a liver biopsy is a barrier to accessing treatment for some people (I think it

is) we would be better to remove it in some cases ?

Merrilee Williams RN, Otago hepatitis C nurse spoke about treating Hepatitis C

next she was knowledgeable and gave a informative presentation.

Michelle MacDonald, Psychiatric Liaison spoke on treating people with Hepatitis

C
and the neuro psychiatric effects of treatment

Depression
Fatigue
Irritability
Insomnia and sleep disturbances

She explained that preexisting mental health issues can and need to be treated

before treatment

Once these conditions are being treated they do not preclude someone from

successfully undertaking treatment.

Bill Jang, Christchurch Hepatitis C Resource Centre Te Waipounamu arrived by

helicopter (well maybe not, but he made a very brief appearance and then left) ,

he made the interesting point that the recent international 1 in 12 hepatitis

campaign was  actually one in forty New Zealanders have hepatitis B or C.

He has begun educating rest homes on Hepatitis C care.

Shame the needle exchange DIVO wasn’t there to advocate for their clients but

again they to seem to be uninterested in their client’s access to care or issues

surrounding Hepatitis C. Not surprising when the local needle exchange is now

entirely governed  and run from Christchurch as a skeleton service.

Wonder how that works with the Ottawa charter on public health. Best just ignore

best practice for public health and instead have our poorly performing health

services controlled from Christchurch.

The good news is there has been an increase in the number of people being treated

in Otago from 24 to 40. I imagine this is the people with genotype three who are

finally getting treatment after Pharmac changed the funding for treatment for

their genotype finally making it accessible.

If we do the calculation that 1% of Otago population has hep c a figure of 1800

people and the Otago/ Southern ? District Heath board treat 40 per year, we can

calculate that in just 45 years everyone would be diagnosed and treated.

Maybe Bill Jang is right about rest homes, assuming the undiagnosed infected live

that long.

It was a good opportunity to see Hepatitis C discussed in the community in such a

positive way a great morning well done to the organisers.

Their were lots of info  / pamphlets available and I picked up a glossy A4 brochure from Roche aimed at raising awareness amongst NZ General Practice Doctors which has to be a good thing.

You and Pegasys Together we can cure hepatitis C Identify and refer patients today.

gptogethercover

Roche pamphlet targeting GP’s.

With 75 % of hepatitis C patients undiagnosed it seems a timely resource

Each New Zealand GP practice on average would have 15 patients.  Most undiagnosed

and untreated.

txtrochegp

North Island Hepatitis C Resource Centre (Te Ika a Maui)

I just found this website for the North Island Hepatitis c Resouce Centre I’m

guessing it’s the replacement for the old site that seems to have disappeared the

Hepatitis C Resource Centre (Te Ika a Maui)   http://www.hepcresources.org.nz/

put on your sunglasses it’s bright with all those virus floating round.

pegypen

Best of Health

www.hcv.org.nz

June 2, 2010

New Zealand Hepatitis C Croydon Day Surgery

NZ Ministry of Health Press Release

2 June 2010

55 Women at Risk of Hep C being Traced

New Zealand and Australian health authorities are tracing 55 New Zealand women who visited a private medical clinic in Australia between 1 January 2006 and 7 December 2009 who may be at risk of having contracted Hepatitis C.

Ministry of Health Deputy Director of Public Health Dr Fran McGrath says Australian authorities identified the link between a cluster of hepatitis C cases and a private medical centre in the State of Victoria, Australia in April and are now investigating how this happened.

There is a police investigation in Victoria and media reports of legal action in Australia being planned.

“The Department of Health in Victoria, has taken responsibility for tracing, directly contacting and confidentially informing all 3,500 women concerned, including the 55 affected women giving a New Zealand address.”

The Department began contacting the New Zealanders yesterday as they worked through the 3500 women being traced. Around 1000 Australian women have been contacted and 746 tested.

Of those tested 44 have been found to have hepatitis C, around half of whom have had their infection linked to the private medical centre.

Because of the difficulties involved in tracing the women, the Ministry of Health will be working more closely with its Victorian counterpart in helping trace the New Zealand women concerned.

New Zealand women who had procedures at the Croydon Day Surgery in Croydon, Victoria from 1 January 2006 to 7 December 2009 can call Healthline in New Zealand and be transferred free of charge to a confidential Australian hepatitis line for further information.

“This is a sensitive and potentially distressing situation and the Ministry of Health here and health authorities in Australia are being careful to protect the privacy and confidentiality of the women involved”, Dr McGrath says.

Specialist staff in District Health Boards in New Zealand are on standby to offer blood testing, follow-up, support and treatment if necessary.

“Based on the results of women tested to date approximately 5% of women treated at the clinic may have contracted Hepatitis C. Based on this information we estimate that up to 3 New Zealand women may test positive.”

Any woman who has received treatment in a Melbourne private clinic in the four years from 2006 to 2009 should contact (New Zealand ) Healthline 0800 611 116 for advice.

Hepatitis C is a blood-borne virus that causes inflammation of the liver and which can have serious complications.

For more information contact Peter Abernethy, Media Relations Manager, 021 366 111

Further information can be found at the Victoria Department of Health website http://www.health.vic.gov.au/chiefhealthofficer/alerts/

Press release ends

Hepatitis C cases linked to doctor grows


AAP

The number of women infected with Hepatitis C after being treated by a Melbourne doctor has grown to 44 and is rising.

Another 32 women have tested positive to the infection after being treated by James Latham Peters, an anaesthetist at a Croydon abortion clinic, the Department of Human Services (DHS) revealed on Monday.

That number is certain to grow and the DHS has urged any women who have had abortions and been treated by Dr Peters at the Croydon Day Surgery to contact them.

The number of women infected with Hepatitis C after being treated by a Melbourne doctor has grown to 44 and is rising.

Another 32 women have tested positive to the infection after being treated by James Latham Peters, an anaesthetist at a Croydon abortion clinic, the Department of Human Services (DHS) revealed on Monday.

That number is certain to grow and the DHS has urged any women who have had abortions and been treated by Dr Peters at the Croydon Day Surgery to contact them.

More than 1100 women treated by Dr Peters since 2008 have been contacted by DHS and told to be tested, with the results of 746 women received showing 32 infection cases, Victoria’s chief health officer Dr John Carnie said.

Dr Carnie and police believe the doctor recklessly and maybe deliberately infected the women by using needles he had contaminated.

“The more cases you find in this instance, it becomes more and more difficult to explain this by any other accidental means,” Dr Carnie told reporters on Monday.

http://news.smh.com.au/breaking-news-national/hepatitis-c-cases-linked-to-doctor-grows-20100531-wpuu.html

best of health

www.hcv.org.nz

May 11, 2010

New Zealand World Hepatitis Day, May 19 2010

New Zealand World Hepatitis Day, May 19 2010  update

A couple of events for world Hepatitis month here in New Zealand

Hepatitis Free concert in Latimer Square Christchurch May 22 nd 11 am – 4 pm

The Hepatitis C Resource Centre Te Waipounamu in conjunction with World Hepatitis Day  proudly present a free concert in Latimer Square Christchurch Saturday May 22 nd 11 am – 4 pm info stalls, Sausage Sizzle,bouncy castle, byo picnic

Lots of Bands Squirm , Dialtones , Mynor Starr ,Anthesiac, Magic Eye, Anthesiac,Papanui High School Jazz combo, ChisnallwoodIntermediate Bands Vivid Distortion, Chain Reaction, Closing Time, 1.5l sprite bottle, DJ Detox Damage.

hepc-gigposter2010
further details contact Hepatitis C Resource Centre Christchurch phone 3663608  email hcv @xtra.co.nz

Opening of the new Hepatitis C Resource Otago Centre office May 19 2010

A great day out in Christchurch and if you make it to the event watch out for  Hepatitis C Resource Centre Dunedin phlebotimist Heath in his band,  Heath will be back in Dunedin on 19 May for the opening of the new Hepatitis C Resource Centre office in Dunedin.

further details contact Heath and  Allison at Otago  Hepatitis C Resource Centre hepcotago @xtra.co.nz

The past month has seen a lead up campaign of  one in twelve hepatitis  awareness ads played nationally on TV 3

best of health

www.hcv.org.nz

May 7, 2010

New Zealand Hepatitis C Blog May 2010

New Zealand Hepatitis C Blog May 2010

World Hepatitis Day, May 19, aims to raise global awareness of hepatitis B and hepatitis C and encourage prevention, diagnosis and treatment.
World Hepatitis Day is led by the World Hepatitis Alliance, which represents 200 patients groups and organizations
http://www.worldhepatitisday.org/en/Home.aspx

The Hepatitis Comics

Have a laugh with Lucinda K. Porter ‘s blog The Hepatitis Comics. Lucinda is hepatitis C positive and positively believes in the power of humour.

http://hepatitiscomics.blogspot.com/

Medical transmission of Hepatitis C from Australia

VICTORIANS worried about their contact with Dr James Latham Peters over the past four years should contact health authorities - not just patients of the doctor in 2008 and 2009, as first stated last week.

A spokesman for the Department of Health last night confirmed that Dr Peters had worked at Croydon Day Surgery - the clinic where he allegedly infected 12 patients with his own strain of hepatitis C - since 2006.

On Friday, Victoria’s chief health officer, Dr John Carnie, said the infected patients had visited the clinic between June 2008 and December last year, and that patients worried about their contact with him at the Croydon clinic during this period should contact the department.

He said departmental workers were also trying to contact patients they believed to be at risk of contracting the blood-borne virus from him during this 18-month period.

But the department spokesman last night said authorities would also encourage patients who visited Dr Peters at Croydon Day Surgery as far back as 2006 to seek further information from the department if they were worried about the virus.

As of last night, the department had received 830 calls from people with questions about the anaesthetist, who is believed to have been using drugs when he infected patients with his particular strain of the illness.

Last week, Dr Carnie said he referred the matter to police in March because he found it hard to imagine how the transmission of the virus had been accidental.

http://www.theage.com.au/victoria/officials-welcome-hepatitis-c-feedback-20100412-s4dx.html

Being Warehoused

‘Warehoused : when patients elect to wait for the new drugs’
Warehoused : Thought this was interesting about waiting for new treatments, I think you might have to wait extra long for pharmac to fund a new treatment in New Zealand. So maybe prepare to be in your warehouse with hep c for a long time ?

Hepatitis C Patients May Boost Merck, J&J, Vertex

http://www.businessweek.com

By Michelle Fay Cortez and Naomi Kresge

April 19 (Bloomberg) — At Fred Poordad’s bustling hepatitis C clinic in the heart of Los Angeles, one in every five patients receives no treatment. They are waiting for a wave of new drugs, expected in the next 18 months, that may boost their chance at a cure by as much as 10-fold.

They’re just the first among new therapies anticipated in the next five years as companies seek a single pill to cure the infection. Poordad, chief of hepatology at the Liver Disease and Transplant Center at Cedars-Sinai Medical Center in Los Angeles, doesn’t object when his patients elect to wait for the new drugs, a practice known as “warehousing.”

“The warehousing has been going on for the past year or so,” Poordad said. “I think we’ll see a tremendous increase in the volume of patients that are treated. That’s the most exciting thing in the field for a long time.”

The drugs closest to market, Merck’s boceprevir and telaprevir from Vertex and Johnson & Johnson, are protease inhibitors crafted from the technologies that led to discoveries made in the fight against HIV. The new treatments are being tested as additions to current standard treatments. Both drugs work by blocking the action of the protease enzyme the hepatitis virus needs to replicate, directly stopping it from spreading.

Warehoused better than a wallet biopsy………….

Telaprevir, has had a trial here in NZ recently, with another trial coming soon.

Adding the investigational drug telaprevir to standard treatment for hepatitis C infection cures about half the patients willing to give therapy a second try. That compares to a cure rate of just 14 percent among those who were re-treated with the standard regimen, according to researchers at Duke Clinical Research Institute.

http://www.youtube.com/watch?v=qwKJQgkdJ2s&feature=player_embedded

Happy Hepatitis month

best of Health

www.hcv.org.nz

April 8, 2010

April Hepatitis C New Zealand Blog

April Hepatitis C New Zealand Blog

How many People are treated for Hepatitis C in New Zealand ?

Someone asked me how many people in New Zealand get treated each year for Hepatitis C in  New Zealand.   I  hadn’t thought about that for a while and it would be nice to think New Zealand are treating more people now that three years ago but apparently not. New Zealand has treated around 400 people per year for Hepatitis C  each year for the last three years. There has been no increase in the numbers treated .

Scotland Hepatitis C

In Scotland a country of comparable size to New Zealand’s the Scottish government have set a goal of treating 2000  extra Hepatitis C patients per year.

New Zealand needs this kind of evidence based national goal to increase the numbers of people being treated.

Scotland Progress to date includes:

* Increasing the number of people treated for hepatitis C. NHS boards will treat around 800 new patients for Hep C in 2009-2010, compared with around 400 in 2007-08

* Significant infrastructure and service development for Hepatitis C treatment, care and support to increase treatment numbers further

* A Hepatitis C Managed Care Network (MCN) within each board area, made up of relevant specialists

* A learning and development lead at each health board to co-ordinate training for professionals who deal with people who have, or may have, the virus

http://www.scotland.gov.uk/News/Releases/2010/03/08094128

I found it interesting that

“Although most people contract hepatitis C through injecting drug use, 8 in 10 people currently infected are not currently injecting drugs.”

Scottish Public Health Minister Shona Robison

Do Needle-Exchange Programs Really Work?

A review of the evidence on the effectiveness of harm reduction interventions involving the provision of sterile injecting equipment in the prevention of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) transmission among injecting drug users (IDUs). The interventions assessed were needle and syringe programmes (NSP), alternative modes of needle/syringe provision (pharmacies, vending machines and outreach) and the provision of injecting equipment other than needles/syringes.

http://www.thebody.com/content/news/art55845.html

“The main public health implications of the findings are that a higher level of coverage of interventions, including [NSPs], is likely required to reduce blood-borne virus transmission,” said Palmateer.

http://www.thebody.com/content/news/art55845.html

More evidence is emerging of the role  your genes play in the success of treatment for Hepatitis C

Duke University has been at the fore front of this research

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

It is well known that many patients will not be cured by treatment, and that patients of European ancestry have a significantly higher probability of being cured than patients of African ancestry. In addition to limited efficacy, treatment is often poorly tolerated because of side effects that prevent some patients from completing therapy. For these reasons, identification of the determinants of response to treatment is a high priority.

http://www.nature.com/nature/journal/v461/n7262/full/nature08309.html

Dr. Andri Rauch discusses his manuscript Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-wide Association Study.

A Facebook  page for Hepatitis C New Zealand Peer Support Project

We  www.hcv.org.nz  “a community of people with Hepatitis C trying to help other people who are affected by Hepatitis C.” have a face book page now you can  check it out here.

http://www.facebook.com/pages/Hepatitis-C-New-Zealand/99254558387

Best of Health www.hcv.org.nz

November 3, 2009

New Zealand Hepatitis C Blog The good news

New Zealand Hepatitis C Blog The good news

The Good News about Coffee

Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease
progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).
The study found that patients with hepatitis C-related bridging fibrosis or cirrhosis who did not respond to standard disease treatment benefited
from increased coffee intake. An effect on liver disease was not observed in patients who drank black or green tea. Findings of the study appear
in the November issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Three cups a day and a 53% lower risk of progression that has to make coffee a good option for those with hep c.

http://www3.interscience.wiley.com/journal/122511224/abstract?CRETRY=1&SRETRY=0

The Good news for new treatment options  Telaprevir

Good news for People with Genotype one Hepatitis C is the latest results of the new drug telaprevir
Cork, Ireland (October 31, 2009) –Tibotec announced today results of a new study (VX950-C208), which showed that sustained virologic response (SVR)
was achieved in more than 80 percent of treatment-naïve patients with chronic genotype 1 hepatitis C virus (HCV) who took telaprevir, administered either
every 8 hours or every 12 hours, in combination with standard of care. Telaprevir, an investigational STAT-C (Specifically Targeted Antiviral Therapy for hepatitis C),
is being co-developed by Tibotec in collaboration with Vertex Pharmaceuticals. The study was presented today at the 60th Annual Meeting of the
American Association for the Study of Liver Diseases (The Liver Meeting).

In the phase II study, which enrolled 161 treatment-naïve genotype 1 patients, rates of SVR (defined as undetectable HCV RNA at 24 weeks after completion of treatment)
ranged from 81 to 85 percent in patients treated with the every 8 hour telaprevir-based regimen, and 82 to 83 percent in patients treated with the every twelve hour regimen.
Adverse events (AEs) were similar to those observed in other trials with telaprevir and were mainly haematologic (anaemia) and cutaneous (rash and pruritus) in nature.

For the vast majority of patients, these high SVR rates were obtained with only 24 weeks of total treatment (half the duration of current standard of care).
Total duration of treatment was decided using a criteria based on treatment response. Subjects who achieved undetectable HCV RNA at week 4
(rapid virologic response or RVR) and maintained this through week 20, were allowed to stop all treatment at week 24. Only 18% of subjects were required to continue standard treatment up to week 48.

Source: Johnson & Johnson Services

Good news for me

My post treatment 24 week viral load came back undetectable

testviralload

The Good news from www.womanaloud.co.uk

Had some good feedback from my last Blog post In particular from Tracy  at  http://www.womanaloud.co.uk/index.html A peer among peers.

” I wish you good health and a sharp pen. Raising awareness of hepatitis C is an uphill struggle… but day by day, one step at a time, it is happening. It is interesting to consider that, if we could get over the brain fog ; D, there are enough of us in the world with this condition, to form our own group/religion/club… if 180 million sufferers were all to shout on the same day, at the same time… mmm … I think I’ll put the kettle on. ”

Thanks Tracy great message. Just off to have a cup of tea myself,  maybe  a coffee as it seems that may be better for me.

Best of Health


www.hcv.org.nz

October 8, 2009

Hepatitis C New Zealand A dark and stormy night

Hepatitis C New Zealand  A dark and stormy night

Public Health Champion 2009 awarded by Public Health Association to Canterbury’s Cheryl Brunton

Dr Brunton’s work with hepatitis C began when she investigated an outbreak at Christchurch Prison in 1991. This led to an on-going interest in hepatitis C research and advocacy. She helped establish the Auckland and Christchurch Hep C support groups, was instrumental in founding the Christchurch Hepatitis C Resource Centre and was the inaugural chair of its trust board. She also took part in the development of the first national Hepatitis C Action plan.

“She continues to arrange conferences, workshops and training on Hep C, played a part in the establishment of the Hepatitis C community clinic in Christchurch, and is part of its advisory group.

I applaud any one working to improve things for people with Hepatitis C long my people care and make a difference, thanks Cheryl from everyone affected by Hepatitis  in New Zealand.

http://www.scoop.co.nz/stories/GE0909/S00025.htm

Prime minister with Hepatitis C

The Prime Minister of Mongolia S.Bayar is the first prime minister to publically announce their hepatitis C Status recently, Bayar was reported to have the viral infectious disease of Hepatitis C before he took office of prime minister. He said that the Prime Minister took a holiday of five working days only since he assumed office in November 2007. In Seoul, Lambaa said, Prime Minister Bayar is now receiving “interferon-based therapy”.

New issue Australian  Hep C  Review magazine available online a good read

The new issue of Australian Hep C magazine is available on line it has some interesting articles about hepatitis C but the one that caught my eye was a   article on drug trials for hepatitis c

Available here.

http://hepmagazines.realviewtechnologies.com/

C-een & Heard speakers program

Inviting a speaker to your agency or organisation provides an opportunity to:
•    Hear first hand personal experiences of people living with hepatitis C
•    Challenge the myths and stereotypes about hepatitis C
•    Address discriminatory attitudes in the workplace and elsewhere
•    Provide a holistic view of health (medical, social, personal)
•    Gain insight into the psychosocial issues associated with hepatitis C
•    Enhance existing training & education initiatives with personal perspectives

Maceon is a guy who lives in Sydney and is involved in community-based education and awareness raising in NSW, Australia. He features in a new DVD produced by the Hepatitis C Council of NSW. It contains stories from several different speakers and is used as a facilitation tool used when our Education and Development team conducts sessions outside the Sydney metropolitan region.

Interesting news story from America about the Hepatitis C hazards of the health care system,

Hep C nurse 20 years jail
Added: 28 September 2009
A former hospital surgical technician who may have infected dozens of surgical patients with hepatitis C by stealing their pain medication and swapping back needles tainted by the virus she carried pleaded guilty on Friday to US federal drug charges. Kristen Parker, 26, could have faced up to life in prison on the most serious charges, but accepted a 20-year prison sentence in a plea agreement with federal prosecutors. Ms. Parker admitted guilt to multiple charges of tampering with a consumer product and obtaining a controlled substance by deceit. Twenty-seven patients at two US hospitals where Ms. Parker worked last year and this year, in Denver and Colorado Springs, have tested positive for a strain of hepatitis C and have been linked to her care, according to state health records. Ms. Parker’s lawyer said outside the courthouse that he thought the lesser sentence was warranted in part by his client’s cooperation with health officials and the police since her arrest this summer

I have been impressed with the English web resource  www.harmreductionworks.org.uk

This website supports the harm reduction works campaign materials. The campaign was developed by Exchange Supplies for the National Treatment Agency as part of the implementation of the Department of Health publication Reducing Drug Related Harm: An Action Plan. The plan commits to reducing the burden of illness and death caused by illicit drug use through improved surveillance of service provision, improved delivery of harm reduction services, and information campaigns aimed at drug users and drug service providers.

http://www.harmreductionworks.org.uk/index.html

Harm reduction works  it has some great information on Hepatitis C  I like this video in particular how small is the hepatitis C Virus is.

Best of Health

www.hcv.org.nz

August 23, 2009

Current Clinical Drug Trials for Hepatitis C In New Zealand

New Zealand has up to six different drug trials currently in progress for Hepatitis C.
1    Recruiting     TMC435-TiDP16-C205: A Phase II Study of TMC435 in Combination With Pegylated Interferon Alpha-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Condition:     Hepatitis C
Interventions:     Drug: PegIFNalpha-2a;   Drug: PegIFNalpha-2a;   Drug: Ribavirin PegIFNalpha-2a;   Drug: Ribavirin PegIFNalpha-2a;   Drug: TMC435 TMC435 Placebo;   Drug: TMC435 Ribavirin;   Drug: TMC435 TMC435 Placebo;   Drug: TMC435 Ribavirin;   Drug: PegIFNalpha-2a;   Drug: TMC435 Placebo Ribavirin

2    Recruiting     A Study of Combination Treatment With an HCV Polymerase Inhibitor (Polymerase Inhibitor) and an HCV Protease Inhibitor (RO5190591) in Genotype 1 Chronic Hepatitis C Patients
Condition:     Hepatitis C, Chronic
Interventions:     Drug: RO5024048/RO5190591;   Drug: RO5024048/RO5190591;   Drug: RO5024048/RO5190591;   Drug: RO5024048/RO5190591;   Drug: RO5024048/RO5190591;   Drug: RO5024048/RO5190591

3    Recruiting     Safety and Efficacy of MK7009 Administered With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV)
Condition:     Chronic Hepatitis C Virus Infection
Interventions:     Drug: Comparator: Peg-INF;   Drug: Comparator: RBV;   Drug: Comparator: MK7009;;   Drug: Comparator: Placebo.;   Drug: Comparator: MK7009.;   Drug: Comparator: MK7009;   Drug: Comparator: Placebo;;   Drug: Comparator: Peg-INF.;   Drug: Comparator: RBV.

4    Recruiting   Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive
Condition:     Hepatitis C
Intervention:     Drug: clemizole hydrochloride

5    Recruiting     Antiviral Activity of AZD7295 in HCV Carriers
Condition:     Hepatitis C
Interventions:     Drug: AZD7295;   Drug: Placebo

6    Recruiting     Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects
Condition:     Hepatitis C
Interventions:     Drug: VCH-222;   Drug: VCH-222;   Drug: VCH-222;   Drug: telaprevir

Interesting to discover so many trials underway in New Zealand and these are just the current ones.  I guess if you want to get on a drug trial you are chosen as opposed to applying in most cases, but its all ways worth asking your medical provider about them.
You can read more detail at this informative site
www.ClinicalTrials.gov

ClinicalTrials.gov United States National Institutes of Health offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions. A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.

When drug trials go Bad

Whenever I think of drug trials I think of guinea pigs and the tragic British drug trials of March 2006, A case of guinea pig beware I guess.
“It was the first time the drug TBN1412, designed to treat conditions such as rheumatoid arthritis and leukaemia, had been tested on humans.
Within hours of taking it on Monday, the six young volunteers had to be admitted to intensive care.
Ms Marshall, 35, whose boyfriend is critically ill, said the normally healthy 28-year-old’s face was so puffed, he “looks like the Elephant Man”.
She said he was completely lifeless, unable even to move an eyelid.
“They just keep saying he’s very, very sick and we are doing all we can,” she added. “

Such clinical trials were essential for the development of new and better treatments

The Medical Research Council said that while it was “an unfortunate and extremely rare event”, such clinical trials were essential for the development of new and better treatments.”

http://news.bbc.co.uk/2/hi/uk_news/england/london/4808836.stm

Best of Heath www.hcv.org.nz

July 2, 2009

Treatment waiting and liver fibrosis Hepatitis C New Zealand

July 2009

Treatment flow chart

I’ve been studying this Treatment flow chart from a New Zealand District Health board.

hepatitis C treatment-flowchart
I’m impressed by the level of detail and it does explain treatment and testing quite well.
Note Under perform liver biopsy we have the standard
Metavir classification for staging of hepatitis C liver disease (Biopsy)  But also some treatment decision information

Fibrosis Scale and Grading

Stage 0 No Fibrosis - No scarring NO TREATMENT RECOMMENDED REPORT BIOPSY IN 4 TO 5 YEARS

Stage 1 Portal fibrosis - Minimal scarring NO TREATMENT RECOMMENDED REPORT BIOPSY IN 4 TO 5 YEARS

Stage 2 Extra portal fibrosis - Scarring has occurred and extends outside the areas in the liver
that contains blood vessels CONSIDER TREATMENT

Stage 3 Bridging fibrosis is spreading and connecting to other areas that contain fibrosis TREAT

Stage 4 Cirrhosis or advanced scarring of the liver

I find it quite incredible that people won’t be treated until they reach advanced liver
Disease.From experience I know you can feel crap and have a really poor quality of life
with hepatitis C, before any fibrosis forms in your liver and the early stages are when
Hepatitis C is most likely to respond to treatment.

Suggesting a person waits until damage is more advanced seems questionable….

Apparently not having a liver biopsy would be is a better option as you “Consider treatment”

Its’ like playing Russian roulette with someone else’s health telling them to wait and see.

I haven’t got  a problem if it’s all explained to the patient and they make a informed decision, But patients are   usually at a disadvantage they lack information to make that decision and trust the health professional they know best….

Wonder how many people are waiting for their liver disease to progress till it becomes  “treatable”

My favourite quote of the month has to be
General (r) Tasawwar Hussain while speaking to audience, however, presented a new concept
saying that the occurrence of hepatitis B & C has increased with the increase in number
of health care facilities across Pakistan. “It convinced me to believe that unnecessary or
unsafe pricking at the health care facilities is one of the major causes of spread of
hepatitis in Pakistan and it should be discouraged religiously by medical professionals.”

So beware at all times of “ unnecessary or unsafe pricking at the healthcare facilities “

Meanwhile in Ireland :Irish Hep C health service faces a struggle

“the creation of a national register for people with hepatitis C, as a result of the lack
of concrete data on the prevalence of the virus amongst the Irish population.

The strategy also states all laboratory requests for hepatitis C serology must
contain full patient identifiers and full clinician details, as many notifications
continue to be incomplete even though it was made a notifiable disease in 2004.

Other recommendations include screening for hepatitis C and other blood-borne
diseases to those who attend services such as needle exchange programmes,
the establishment of an expert group to provide governance on clinical issues,
the development of interventions to delay and prevent transition from smoking
to injecting, the provision of supports to attend treatment, and the development
of peer support networks.

The most important requirement for drug clinics treating hepatitis C patients
is to have a clinical nurse specialist to coordinate and help administer care,
according to Dr Troy. “

New Zealand Hep C plan

Sounds good still waiting for the New Zealand Hep C plan I asked Hon Tony Ryall
our minister of health for a copy last week, wonder how long will have to wait to
see a copy of that……

Not as long as you going to have to wait for treatment if you live in ? which New Zealand Distinct Health Board

Best of Health

www.hcv.org.nz

June 23, 2009

Treatment responses Hepatitis C

Hepatitis C Treatment New Zealand District Health Boards

Ive been busy chasing District Health Boards to reply to our Hepatitis C treatment questions, Only three of the twenty one district health boards are yet to produce a reply and only one has ignored the request.

Treatment Outcomes and Terminology

There has been a bit of a discussion on the forums lately about monitoring treatment and the terminology
Rapid Viral Response: viral clearance at week four of treatment.
Early Viral Response (complete): viral clearance at week 12 of treatment.
Early Viral Response (partial): Significant drop in viral load at week 12 of treatment, ie. two log drop in viral load, eg. from 60,000 down to 600.
Non-Response: no significant drop in viral load after twelve weeks of treatment. This means you probably won’t be cured.
End-of-Treatment Response: whether or not the virus is detectable in your blood at the end of treatment (either six months or twelve months). This is good but it
doesn’t mean you are cured.
Sustained Viral Response: viral clearance as proved by a negative PCR result six months or more after treatment finishes. This is the result that people hope
for and is what doctors refer to when someone is successfully cured

http://www.hepc.org.au/documents/2009WYNTKweb-2MB.pdf

this info is from the new hep c council of NSW website  http://www.hepc.org.au/index.php?article=content/home

well worth a look.

Some Hepatitis C related video’s this blog


First up Teenager Jazzy was born with hepatitis C. This is her video diary about living with the condition
Produced and directed by Jazzy De Lisser “I will try treatment again”

A series of  informative videos from Nicole Cutler describes the various methods by which Hepatitis C is transmitted. www.hepatitis-central.com

Transmission

I  have been watching MusicKey ’s hepatitis C treatment Journey for a while now , GO MUSIC KEY  beat the virus

Another hepatitis C treatment video blog here

lots of encouragement to anyone on treatment and those contemplating it

best of health

www.hcv.org.nz

Older Posts »

Powered by WordPress